Growth patterns among HIV-exposed infants receiving nevirapine prophylaxis in Pune, India

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Ram, Malathi ^a   Gupte, Nikhil ^b   Nayak, Uma ^e   Kinikar, Aarti A ^c   Khandave, Mangesh ^b   Shankar, Anita V ^a   Sastry, Jayagowri ^f   Bollinger, Robert C ^a,d   Gupta, Amita ^a,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b BJMC JHU Clinical Trials Unit   (India)

^c B J MEDICAL COLLEGE   (India)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

^f Shrimati Kashibai Navale Medical College and General Hospital   (India)

Author keywords

Extended use of nevirapine; Growth patterns; HIV exposed infants; India; Risk factors; Timing of HIV Infection

Indexed keywords

NEVIRAPINE;

ARTICLE; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CHILD GROWTH; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FETUS OUTCOME; GESTATIONAL AGE; GROWTH CURVE; HIGH RISK INFANT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFANT; INFECTION PREVENTION; INSTRUMENTAL DELIVERY; INTRAUTERINE INFECTION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NEWBORN MONITORING; NEWBORN MORBIDITY; PHASE 3 CLINICAL TRIAL (TOPIC); RISK ASSESSMENT; SINGLE DRUG DOSE; STUNTING; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION; WASTING SYNDROME;

ADULT; ANTHROPOMETRY; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INDIA; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; NEVIRAPINE; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; THINNESS;

EID: 84868225521     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-282     Document Type: Article

References (49)

1. De Onis M, Frongillo EA, Blössner M. Is malnutrition declining? An analysis of changes in levels of child malnutrition since 1980. Bull World Health Organ 2000, 78:1222-1233. 2560621, 11100617.
2. Pelletier DL, Frongillo EA, Habicht J-P. Epidemiologic evidence for a potentiating effect of malnutrition on child mortality. Am J Pub Health 1993, 83:1130-1133.
3. Pelletier DL, Frongillo EA, Schroeder DG, Habicht J-P. A methodology for estimating the contribution of malnutrition to child mortality in developing countries. J Nutr 1994, 124(10 Suppl):2106S-2122S.
4. Pelletier DL, Frongillo EA, Schroeder DG, Habicht J-P. The effects of malnutrition on child mortality in developing countries. Bull World Health Organ 1995, 73:443-448. 2486780, 7554015.
5. Caulfield LE, de Onis M, Blossner M, Black RE. Undernutrition as an underlying cause of child deaths associated with diarrhea, pneumonia, malaria, and measles. Am J Clin Nutr. 2004, 80(1):193-198.
6. Moye J, Rich KC, Kalish LA, Sheon AR, Diaz C, Cooper ER, Pitt J, Handelsman E. Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. J Pediatr 1996, 128:58-69. 10.1016/S0022-3476(96)70428-6, 8551422.
7. McKinney R, Robertson WR. Effect of human immunodeficiency virus infection on the growth of young children. J Pediatr 1993, 123:579-582. 10.1016/S0022-3476(05)80955-2, 8410511.
8. Berhane R, Bagenda D, Marum L, Aceng E, Ndugwa C, Bosch RJ, Olness K. Growth failure as a prognostic indicator of mortality in pediatric HIV infection. Pediatrics 1997, 100:1-4. 10.1542/peds.100.1.e7, 9200353.
9. Isanaka S, Duggan C, Fawzi WW. Patterns of postnatal growth in HIV-infected and HIV-exposed children. Nutr Rev 2009, 67(6):343-359. 10.1111/j.1753-4887.2009.00207.x, 2771338, 19519675.
10. Bobat R, Coovadia H, Moodley D, Coutsoudis A, Gouws E. Growth in early childhood in a cohort of children born to HIV-1-infected women from Durban, South Africa. Ann Trop Paediatr 2001, 21:203-210. 10.1080/02724930120077772, 11579858.
11. Arpadi SM, Cuff PA, Kotler DP, Wang J, Bamji M, Lange M, Pierson RN, Matthews DE. Growth velocity, fat-free mass and energy intake are inversely related to viral load in HIV-infected children. J Nutr 2000, 130:2498-2502.
12. Miller TL, Evans SJ, Orav EJ, Morris V, McIntosh K, Winter HS. Growth and body composition in children infected with human immunodeficiency virus-1. Am J Clin Nutr 1993, 57:588-592.
13. Lepage P, Msellati P, Hitimana DG, Bazubagira A, Van Goethem C, Simonon A, Karita E, Dequae-Merchadou L, Van de Perre P, Dabis F. Growth of human immunodeficiecy type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993. Pediatr Infect Dis J 1996, 15(6):479-485. 10.1097/00006454-199606000-00003, 8783343.
14. Pollack H, Glasberg H, Lee E, Nirenberg A, David R, Krasinski K, Borkowsky W, Oberfield S. Impaired early growth of infants perinatally infected with human immunodeficiency virus: Correlation with viral load. J pediatr 1997, 130(6):915-922. 10.1016/S0022-3476(97)70277-4, 9202613.
15. Agostoni C, Zuccotti GV, Giovannini M, Decarlis S, Giannì ML, Piacentini E, D'Auria E, Riva E. Growth in the first two years of uninfected children born to HIV-1 seropositive mothers. Arch Dis Child 1998, 79:175-178. 10.1136/adc.79.2.175, 1717652, 9797604.
16. Bailey RC, Kamenga MC, Nsuami MJ, Nieburg P. St Louis ME. Growth of children according to maternal and child HIV, immunological and disease characteristics: a prospective cohort study in Kinshasa, Democratic Republic of Congo. Int J Epidemiol 1999, 28:532-540. 10.1093/ije/28.3.532, 10405861.
17. Chantry CJ, Byrd RS, Englund JA, Baker CJ, McKinney RE, Pediatric AIDS. Clinical Trials Group Protocol 152 Study Team. Growth, Survival and Viral Load in symptomatic childhood human immunodeficiency virus infection. Pediatr Infect Dis J 2003, 22:1033-1038. 10.1097/01.inf.0000100575.64298.bc, 14688560.
18. Benjamin DK, Miller WC, Benjamin DK, Ryder RW, Weber DJ, Walter E, McKinney RE. A comparison of height and weight velocity as a part of composite endpoint in pediatric HIV. AIDS 2003, 17:2331-2336. 10.1097/00002030-200311070-00007, 14571184.
19. Newell ML, Borja MC, Peckham C. European Collaborative Study. Height, weight and growth in children born to mothers with HIV-1 infection in Europe. Pediatrics 2003, 111:52-60. 10.1542/peds.111.1.e52, 12509554.
20. Villamor E, Fataki MR, Bosch RJ, Mbise RL, Fawzi WW. Human immunodeficiency virus infection, diarrheal disease and sociodemographic predictors of child growth. Acta Paediatr 2004, 93:372-379. 10.1111/j.1651-2227.2004.tb02964.x, 15124842.
21. National Family Health Survey (NFHS-3) National Fact Sheet India 2005-2006, (Provisional Data) http://www.nfhsindia.org/pdf/IN.pdf, National Family Health Survey (NFHS-3).
22. Six Week Extended-Dose Nevirapine (SWEN) Study Team Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 2008, 372:300-313. Six Week Extended-Dose Nevirapine (SWEN) Study Team.
23. WHO Anthro for personal computers, version 2, 2007 Software for assessing growth and development of the world's children 2007, http://www.who.int/childgrowth/software/en/, WHO Anthro for personal computers, version 2, 2007.
24. Multicentre Growth Reference Study Group WHO Child Growth Standards: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and development 2006, Geneva: World Health Organization, Multicentre Growth Reference Study Group.
25. STATA Version 10 software for personal computers, Santa Monica CA: Computing Resource Center STATA Version 10 software for personal computers, Santa Monica.
26. WHO Global Database on Child Growth and Malnutrition WHO Global Database on Child Growth and Malnutrition, http://www.who.int/nutgrowthdb/database/countries/who_standards/ind.pdf, WHO Global Database on Child Growth and Malnutrition.
27. Seth A, Chandra J, Gupta R, Kumar P, Aggarwal V, Dutta A. Outcome of HIV Exposed Infants: Experience of a Regional Pediatric Center for HIV in North India. Indian J Pediatr 2012, 79(2):188-193. 10.1007/s12098-011-0532-8, 21785862.
28. Padmapriyadarsini C, Pooranagangadevi K, Chandrasekaran K, Subramanyan S, Thiruvalluvan C, Bhavani PK, Swaminathan S. Prevalence of Underweight, Stunting, and Wasting among Children Infected with Human Immunodeficiency Virus in South India 2009,
29. Webb AL, Manji K, Fawzi WW, Villamor E. Time-independent Maternal and Infant Factors and Time-dependent Infant Morbidities including HIV Infection, Contribute to Infant Growth Faltering during the First 2 Years of Life. J Trop Pediatr 2009, 55(2):83-90. Epub 2008 Aug 22, 2734313, 18723575.
30. Lodha R, Upadhyay A, Kapoor V, Kabra SK. Clinical profile and natural history of children with HIV infection. Indian J Pediatr 2006, 73:201-204. 10.1007/BF02825480, 16567911.
31. Lodha R, Upadhyay A, Kabra SK. Antiretroviral Therapy in HIV-1 Infected Children. Indian J Pediatr 2005, 42:789-796.
32. Banerjee T, Pensi T, Banerjee D, Grover G. Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India. Ann Trop Paediatr 2010, 30(1):27-37. 10.1179/146532810X12637745451915, 20196931.
33. Bandyopadhyay A, Bhattacharyya S. Effect of pre-existing malnutrition on growth parameters in HIV-infected children commencing antiretroviral therapy. Ann Trop Paediatr 2008, 28(4):279-285. 10.1179/146532808X375440, 19021944.
34. Pooranagangadevi C, Chandrasekaran K, Bhavani PK, Thiruvalluvan C, Swaminathan S. Persistence of Stunting after Highly Active Antiretroviral Therapy in HIV-Infected Children in South India. Indian Pediatr 2011, 48:333-334.
35. Guillén S, Ramos JT, Resino R, Bellón JM, Muñoz MA. Impact on weight and height with the use of HAART in HIV-infected children. Pediatr Infect Dis J 2007, 26:334-338. 10.1097/01.inf.0000257427.19764.ff, 17414398.
36. Kabue MM, Kekitiinwa A, Maganda A, Risser JM, Chan W, Kline MW. Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious disease clinic in Uganda. AIDS Patient Care STDS 2008, 22(3):245-251. 10.1089/apc.2007.0049, 18298315.
37. Nachman SA, Lindsey JC, Moye J, Stanley KE, Johnson GM, Krogstad PA, Wiznia AA, Pediatric AIDS. Clinical Trials Group 377 Study Team. Growth of Human Immunodeficiency virus-infected children receiving highly activie antiretroviral therapy. Pediatr Infect Dis J 2005, 24:352-357. 10.1097/01.inf.0000157095.75081.43, 15818296.
38. Wamalwa DC, Farquhar C, Obimbo EM, Selig S, Mbori-Ngacha DA, Richardson BA, Overbaugh J, Emery S, Wariua G, Gichuhi C, et al. Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children. J Acquir Immune Defic syndr 2007, 45:311-317. 3380073, 17356470.
39. Palumbo P, Lindsey JC, Hughes MD, Cotton MF, Bobat R, Meyers T, Bwakura-Dangarembizi M, Chi BH, Musoke P, Kamthunzi P, et al. Antiretroviral treatment for children with peripartum nevirapine exposure. N Engl J Med 2010, 363(16):1510-1520. 10.1056/NEJMoa1000931, 3021781, 20942667.
40. Jackson JB, Dick J, Tekle T, Simmons A, Carroll KC. Lack of antimicrobial activity by the antiretroviral drug nevirapine against common bacterial pathogens. Antimicrob Agents Chemother 2009, 53(8):3606-3607. 10.1128/AAC.01583-08, 2715610, 19487448.
41. Young S, Murray K, Mwesigwa J, Natureeba P, Osterbauer B, Achan J, Arinaitwe E, Clark T, Ades V, Plenty A, et al. Maternal Nutritional Status Predicts Adverse Birth Outcomes among HIV-Infected Rural Ugandan Women Receiving Combination Antiretroviral Therapy. PLos ONE 7(8):41934.
42. Frost MB, Forste R, Haas DW. Maternal education and nutritional status in Bolivia: finding the links. Soc Sci Med 2005, 60(2):395-407. 10.1016/j.socscimed.2004.05.010, 15522494.
43. Wachs TD, Creed-Kanashiro H, Cueto S, Jacoby E. Maternal education and Intelligence predict offspring diet and nutritional status. J Nutr 2005, 135:2179-2186.
44. Semba RD, de Pee S, Sun K, Sari M, Akhter N, Bloem MW. Effect of parental formal education on risk of child stunting in Indonesia and Bangladesh: a cross-sectional study. Lancet 2008, 371:322-328. 10.1016/S0140-6736(08)60169-5, 18294999.
45. Briand N, Le Coeur S, Traisathit P, Karnchanamayul V, Hansudewechakul R, Ngampiyasakul C, Bhakeecheep S, Ithisukanan J, Hongsiriwon S, McIntosh K, et al. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of Mother-to-child human immunodeficiency virus transmission. Pediatr Infec Dis J 2006, 25:325-332.
46. Zemel BS, Riley EM, Stallings VA. Evaluation of methodology for nutritional assessment in children: anthropometry, body composition, and energy expenditure. Ann Rev Nutr 1997, 17:211-235.
47. Patel D, Bland R, Coovadia H, Rollins N, Coutsoudis A, Newell ML. Breastfeeding, HIV status and weights in South African Children: a comparison of HIV-exposed and unexposed children. AIDS 2010, 24:437-445. 10.1097/QAD.0b013e3283345f91, 19915445.
48. Thea DM, St Louis ME, Atido U, Kanjinga K, Kembo B, Matondo M, Tshiamala T, Kamenga C, Davachi F, Brown C, et al. A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants. N Engl J Med 1993, 329:1696-1702. 10.1056/NEJM199312023292304, 8232458.
49. Chisenga M, Kasonka L, Makasa M, Sinkala M, Chintu C, Kaseba C, Kasolo F, Tomkins A, Murray S, Filteau S. Factors affecting duration of exclusive breastfeeding among HIV-infected and -uninfected women in Lusaka, Zambia. J Hum Lact 2005, 21:266-275. 10.1177/0890334405279251, 16113015.